News UMass Amherst Receives $833,000 Pentagon Grant to Create Improved MS Diagnostic Test UMass Amherst Receives $833,000 Pentagon Grant to Create Improved MS Diagnostic Test by Patricia Silva, PhD | March 13, 2017 Share this article: Share article via email Copy article link Team members are professor Richard van Emmerik, back row left, consultant John Buonaccorsi and professor Jane Kent. Front row from left are graduate research assistant Julianna Averill, postdoctoral researcher Jongil Lim and graduate research assistant Julia Miehm. (Photo courtesy of UMass Amherst) Kinesiology professor Richard van Emmerik and his colleagues at the University of Massachusetts AmherstĀ recently received a two-year $833,000 grant from the U.S.Ā Department of Defense to create an improved diagnostic test for multiple sclerosis (MS). The scientists expects their research toĀ help an estimated 2.3 million people worldwideĀ who live with theĀ disease, one million of whom have progressive MS. āThe goal of our test is to accurately track the progression of symptoms in patients and clearly diagnose them with either progressive or non-progressive MS,ā Van Emmerik said in a news release. The scientists’ premise is that no effective methods are currently available to treat and provide a timely diagnosis for the nearly half of MS patients for whom the disease steadily worsens. TheirĀ aim is to change this by developing a test that can accuratelyĀ and preciselyĀ detect the most subtle changes in sensory and motor function. The project will have two parts. In the first, researchers will develop new standardized measures for symptoms of progressive MS such as footĀ sensitivity, ability to sense movement, the position of joints in the lower body, limb coordination and overall ability to walk without help. In the second,Ā researchers will track participantsā progress using the new measures. Van Emmerik said he expects results to be available as soon as the two-year grant ends, with new methods to help patients with progressive MS receive treatment to be made available to clinicians and researchers right after that. āWe want to understand how sensation and motor function change in those with progressive MS by repeating these measurements every six months,” he said. “The ultimate goal is to develop a process that will detect small changes in patients so clinicians and researchers can develop effective, early treatments to slow disability progression in those with MS and maintain or improve their quality of life.” The initiative is a partnership between UMass Medical Schools Department of Clinical Neurology and the department of kinesiology at the UMass Amherst School of Public Health and Health Sciences. Print This Page About the Author Patricia Silva, PhD PatrĆcia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. PatrĆcia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles. Tags motor function, progressive MS
April 22, 2024 News by Marisa Wexler, MS AAN 2024: Briumvi found to ease disability in certain MS patients
April 22, 2024 Columns by Desiree Lama Learning to manage cognitive impairment with multiple sclerosis
April 19, 2024 News by Lindsey Shapiro, PhD AAN 2024: Earlier Ocrevus lowers MS progression risk over 10 years